Home › GLP-1 Medications › Semaglutide
Latest four-week snapshot through 2026-08-05 · 1 wave. Use the controls above to change the window.
GLP-1 Medications · 1 wave · n=72 answers, pooled
How often each assistant brings the brand up in recommendation answers.
| assistant | share of voice | answers |
|---|---|---|
| ChatGPT | 4% | 1 of 24 |
| Claude | 0% | 0 of 24 |
| Gemini | 0% | 0 of 24 |
Wave-by-wave share of recommendation answers that named this brand.
| wave | share of voice | answers | change |
|---|---|---|---|
| 2026-08-05 | 1% | 1 of 72 |
Recurring descriptions in the assistants' own words, grouped by theme.
“current diabetes guidance generally favors higher-weight-loss options such as semaglutide or tirzepatide when clinically appropriate.”
“**Short answer:** Saxenda can be worth it if you meet medical criteria, can tolerate a **daily injection**, and insurance makes the cost reasonable—but it is no longer usually the strongest-value GLP-1 option when weekly alternatives are covered.”
“## Compounded Tirzepatide/Semaglutide”
“** Trulicity can cause weight loss, but it is *not* FDA-approved specifically for weight management, and current ADA guidance considers semaglutide or tirzepatide generally more effective for both glucose lowering and weight loss.”
“If you have needle phobia or find the logistics of keeping injectable pens refrigerated (especially while traveling) frustrating, a pill is highly convenient.”
“Many patients turn to compounded semaglutide from accredited compounding pharmacies, which typically costs $199 to $399 per month.”
“For type 2 diabetes with overweight/obesity where **maximum weight loss** is the main priority, current ADA guidance preferentially identifies semaglutide or tirzepatide as the higher-weight-loss options.”
“- **Ozempic/semaglutide, Trulicity/dulaglutide, and Mounjaro/tirzepatide** may be preferred by insurance or have stronger glucose/weight benefits for some people, but they are usually expensive without coverage.”
“A different GLP-1—such as dulaglutide, semaglutide, exenatide, or lixisenatide—may cost less *on your specific formulary*”
“It is generally less effective than weekly semaglutide for weight loss: a head-to-head trial reported about **6.4%** mean loss with liraglutide versus **15.8%** with semaglutide 2.4 mg at 68 weeks, both alongside lifestyle counseling.”
25 exact quoted mentions in this snapshot, grouped by coded tone.
“ADA's 2026 guidance identifies tirzepatide and semaglutide as the highest-efficacy currently available options for both glucose lowering and weight loss.”
“A direct 2025 comparison found tirzepatide produced greater average loss than semaglutide—20.2% vs. 13.7% at 72 weeks—though either medication can be appropriate depending on tolerability, access, and health history.”
“If your primary aim is major weight loss or you need the strongest glucose/weight effect, an injectable semaglutide or tirzepatide option may be more effective”
“It has also outperformed semaglutide in a head-to-head 72-week obesity trial.”
“Trulicity can cause weight loss, but it is *not* FDA-approved specifically for weight management, and current ADA guidance considers semaglutide or tirzepatide generally more effective for both glucose lowering and weight loss.”
“Be especially skeptical if the seller is a telehealth, wellness, or "GLP-1 program" company rather than the manufacturer of an FDA-approved drug. **Compounded** semaglutide or tirzepatide is not FDA-approved”
“Landmark clinical trials (like the STEP and OASIS trials for semaglutide) have proven that these medications can help patients lose 10% to 22% of their body weight, significantly improve blood sugar control, and lower the risk of major adve”
“Some providers advertise compounded tirzepatide starting even lower, around $125–$249/month, and compounded semaglutide often starting around $99–$199/month.”
“Mounjaro is a dual-action drug — it provides all effects of semaglutide, plus improved adipose tissue sensitivity via GIP”
“in one 40-week comparison with semaglutide 1 mg, Mounjaro 15 mg lowered A1C by 2.3 points and body weight by 11.2 kg on average.”
“Avoid assuming compounded "semaglutide" is an equivalent bargain”
“Some telehealth services offer compounded semaglutide at lower prices (e.g., a formulation that contains the same active ingredient, offered by some providers for around $279 per month), but note that compounded semaglutide is not FDA-appro”
“FDA says tirzepatide and semaglutide are no longer on its shortage list, and it has raised concerns about fraudulent products, dose errors, and adverse-event reports involving compounded GLP-1 drugs.”
Which competitors assistants suggest when shoppers ask for something cheaper.
2 of 25 mentions appear alongside an identifiable web citation. Citation does not establish causation.
| cited source | mentions |
|---|---|
| appliedclinicaltrialsonline.com | 1 |
| formblends.com | 1 |
Method: fixed shopper questions asked repeatedly to Claude, OpenAI GPT and Gemini with web search on. Shares are the percentage of recommendation answers mentioning the brand. Quotes are AI outputs; full transcripts are kept as receipts.